{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:14:04Z","timestamp":1790720044030,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpmfocus.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJPM Focus"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.focus.2023.100134","type":"journal-article","created":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T09:57:25Z","timestamp":1690711045000},"page":"100134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Trends in Recommended Screening and Monitoring Tests for Users of HIV Pre-Exposure Prophylaxis Before and During the COVID-19 Pandemic"],"prefix":"10.1016","volume":"2","author":[{"given":"Ikenna F.","family":"Unigwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7770-3754","authenticated-orcid":false,"given":"Robert L.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1613-8229","authenticated-orcid":false,"given":"Jennifer W.","family":"Janelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3299-8111","authenticated-orcid":false,"given":"Haesuk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.focus.2023.100134_bib0001","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jama.2020.7312","article-title":"Trends in HIV preexposure prophylaxis prescribing in the United States, 2012\u20132018","volume":"324","author":"Song","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.focus.2023.100134_bib0002","series-title":"Preexposure Prophylaxis for the Prevention of HIV Infection in the United States - 2017 Update \u2013 A Clinical Practice Guideline","year":"2017"},{"issue":"4","key":"10.1016\/j.focus.2023.100134_bib0003","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/infdis\/jix595","article-title":"Laboratory testing of a cohort of commercially insured users of HIV preexposure prophylaxis in the United States, 2011\u20132015","volume":"217","author":"Huang","year":"2018","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.focus.2023.100134_bib0004","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s10461-020-02860-y","article-title":"Collective call to action for HIV\/AIDS community-based collaborative science in the era of COVID-19","volume":"24","author":"Shoptaw","year":"2020","journal-title":"AIDS Behav"},{"key":"10.1016\/j.focus.2023.100134_bib0005","unstructured":"MarketScan research databases. IBM. https:\/\/www.ibm.com\/products\/marketscan-research-databases. Accessed April 16, 2022."},{"issue":"2","key":"10.1016\/j.focus.2023.100134_bib0006","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/cid\/ciw701","article-title":"Uptake of HIV preexposure prophylaxis among commercially insured persons-united states, 2010\u20132014","volume":"64","author":"Wu","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.focus.2023.100134_bib0007","unstructured":"Introduction to billing code systems. American Speech-Language-Hearing Association. https:\/\/www.asha.org\/practice\/reimbursement\/coding\/code_intro\/. Accessed February 20, 2023."},{"issue":"6","key":"10.1016\/j.focus.2023.100134_bib0008","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.focus.2023.100134_bib0009","article-title":"Impact of the COVID-19 pandemic on HIV testing rates across four geographically diverse urban centres in the United States: an observational study","volume":"7","author":"Moitra","year":"2022","journal-title":"Lancet Reg Health Am"},{"issue":"14","key":"10.1016\/j.focus.2023.100134_bib0010","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.14.2100503","article-title":"HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019","volume":"27","author":"Koppe","year":"2022","journal-title":"Euro Surveill"},{"issue":"11","key":"10.1016\/j.focus.2023.100134_bib0011","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1093\/jac\/dkab263","article-title":"PrEP monitoring and HIV incidence after PrEP initiation in France: 2016\u201318 nationwide cohort study","volume":"76","author":"Tassi","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.focus.2023.100134_bib0012","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-3996","article-title":"Considerations for addressing low HIV testing rates among adolescent men who have sex with men","volume":"145","author":"Fields","year":"2020","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.focus.2023.100134_bib0013","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/OLQ.0000000000001265","article-title":"Women are less likely to be tested for HIV or offered preexposure prophylaxis at the time of sexually transmitted infection diagnosis","volume":"48","author":"Yumori","year":"2021","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.focus.2023.100134_bib0014","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/jcm11010071","article-title":"Trends in sexually transmitted infections in United States ambulatory care clinics from 2005\u20132016","volume":"11","author":"Unigwe","year":"2022","journal-title":"J Clin Med"}],"container-title":["AJPM Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773065423000718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773065423000718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T14:51:15Z","timestamp":1757429475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2773065423000718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2773065423000718"],"URL":"https:\/\/doi.org\/10.1016\/j.focus.2023.100134","relation":{},"ISSN":["2773-0654"],"issn-type":[{"value":"2773-0654","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in Recommended Screening and Monitoring Tests for Users of HIV Pre-Exposure Prophylaxis Before and During the COVID-19 Pandemic","name":"articletitle","label":"Article Title"},{"value":"AJPM Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.focus.2023.100134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of The American Journal of Preventive Medicine Board of Governors.","name":"copyright","label":"Copyright"}],"article-number":"100134"}}